Bob Rauker, CEO of Plano-based medical device company Belluscura, one of two Dallas-area life science companies to go public in London this summer, will outline the reasoning for and benefits of accessing capital this way in a fireside chat with Rachel Carroll, President & Managing Partner of Edison Group, a global independent equity research and investor relations company.